Handelsavisen
prelaunch
Companies Financials AXAF.PA
AX
AXAF.PA Euronext Paris Life & Health Insurance

Axa Sa

€40,86
Open in Charts → Attach watcher ⌖
EUR
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
5,67 %
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

AXA SA is a multinational insurance company that provides life and health insurance products, generating revenue through premium income and investment returns.

Business. AXA SA (AXAF.PA) is a life and health insurance company headquartered in France and primarily listed on the Euronext Paris. The firm operates within the Financials sector, generating revenue through a premium-income model typical of the insurance industry. Specific details regarding its operating segments and geographic mix are not provided in the available data.

Classification92 %
SectorFinancials
Business sectorInsurance
IndustryLife & Health Insurance
Generated · model-assisted
Sell-side consensus
BUY22 analysts
19 buy3 hold0 sell
Avg 12m price target45,97

Analyst recommendations

22 analysts · consensus Buy
Buy19
Hold3
Sell0
12-month price target
45,97
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
22 analysts · indicative
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning AXAF.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to AXAF.PA. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    AXA SA (AXAF.PA) is a life and health insurance company headquartered in France and primarily listed on the Euronext Paris. The firm operates within the Financials sector, generating revenue through a premium-income model typical of the insurance industry. Specific details regarding its operating segments and geographic mix are not provided in the available data.

    Classification92 %
    SectorFinancials
    Business sectorInsurance
    IndustryLife & Health Insurance
    AI synthesis
    GENERATED

    AXA SA's capital structure is characterized by a lack of dilution risk, as shares outstanding for both basic and diluted scenarios are identical at 2.06 billion shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's valuation snapshot is currently unavailable, but its price targets suggest a range of 40.00 EUR to 50.70 EUR, with a mean of 45.97 EUR and a median of 46.82 EUR.

    Profitability and returns are not currently quantifiable due to the absence of valuation snapshot data. However, as a life and health insurer, AXA's performance is typically measured by metrics such as combined ratio, underwriting margin, and investment yield. These metrics are not provided in the current dataset, so a direct comparison to industry medians is not possible.

    AXA's revenue is derived from its global operations, but the specific geographic and segment breakdown is not disclosed in the available data. The company operates in a highly regulated and competitive environment, and its exposure to regional markets is likely significant, though the exact concentration is not quantified in the input data.

    Growth trajectory is not explicitly outlined in the input data, but analyst price targets suggest a relatively stable outlook. The mean recommendation of 1.91 indicates a slight bias toward positive sentiment, with 5 strong-buy and 14 buy ratings. No specific revenue history or growth rates are provided to support a more detailed growth narrative.

    Risk factors include the inability to assess liquidity risk, which is a concern for any financial institution. The company is also exposed to regulatory and market risks inherent to the insurance industry, such as claims volatility and interest rate sensitivity. Dilution risk is currently low, as no dilution potential is reported in the data.

    Recent events, such as filings or transcripts, are not included in the input data, so no specific recent developments can be cited. Analysts' price targets and recommendations are the most recent signals of market sentiment.

    Key takeaways
    • AXA SA has no dilution risk as of the latest data, with basic and diluted shares outstanding being equal.
    • Analysts have a generally positive outlook, with a mean recommendation of 1.91 and a median price target of 46.82 EUR.
    • Liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents.
    • The company's profitability and returns are not currently quantifiable due to the absence of valuation snapshot data.
    • AXA's geographic and segment revenue concentration is not disclosed in the available data.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2026-02-26
    FY 2026 · Full-year highlights

    Operating income −0,4% YoY; Net income +24,2% YoY.

    Revenue
    Operating income€10.37B−0,4 % YoY
    Net income€9.80B+24,2 % YoY
    Free cash flow
    EPS
    Operating cash flow€22.35B+79,3 % YoY
    Financials
    Income statement
    Revenue
    Gross profit
    Operating income€10.37B
    Net income€9.80B
    Balance sheet
    Total assets€635.54B
    Total liabilities€588.37B
    Total equity€47.17B
    Cash & equivalents€22.25B
    Long-term debt€22.49B
    Cash flow
    Operating cash flow€22.35B
    CapEx-€428.0M
    Free cash flow
    SBC
    Highlights
    • Operating income −0,4% YoY
    • Net income +24,2% YoY

    Valuation FY

    Market price
    €40,86
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    4,12
    Predicted surprise
    -0,03
    Beat probability
    45 %
    Analysts
    21
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    revision ratio -0,01 · as of 2026-06-24 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate4,12
    Revenueno estimateno estimate94,5B EUR
    Operating incomeno estimateno estimate10,4B EUR
    Full-year consensus mean (period as reported by source) · consensus in EUR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution21 analysts
    Strong buy5
    Buy13
    Hold3
    Sell0
    Strong sell0
    12-month price target€47,65 · Median €46,91
    Low €40,00High €77,10
    Operating income · consensus10,4B EUR
    EPS surprise
    −6,4 %
    reported vs consensus · miss
    Revenue surprise
    +22,2 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low€40,00
    Mean€45,97
    Median€46,82
    High€50,70
    Spot€40,86
    +12.5 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • AXA SA Market data — financials · 2026-05-27
    • AXA SA Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Leadership

    • Thomas BuberlChief Executive Officer, Executive Director

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AXAF.PACanonical
    Euronext Paris · EUR

    Intel & risk

    PredictorBeat prob45 %Surprise-0,03Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-02-26 05:45 UTCEARNINGSAnnual results — FY 2026 Net EUR 9.80B
    2025-03-19 09:10 UTCEARNINGSAnnual results — FY 2025 Net EUR 7.89B
    2024-02-22 08:06 UTCEARNINGSAnnual results — FY 2024 Net EUR 7.19B
    2023-02-23 06:00 UTCEARNINGSAnnual results — FY 2023 Net EUR 5.06B
    2022-02-24 14:42 UTCEARNINGSAnnual results — FY 2022 Net EUR 7.29B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage